{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:09:54Z","timestamp":1791263394476,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005196.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000}}],"reference-count":65,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005196.pub4","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T08:43:37Z","timestamp":1359449017000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour"],"prefix":"10.1002","volume":"2016","author":[{"given":"Linyu","family":"Deng","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; National Key Laboratory of Biotherapy and Cancer Centre; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"West China Second University Hospital, West China Women's and Children's Hospital; Department of Obstetrics and Gynecology; No. 20, 3rd section, Renmin South Road Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taixiang","family":"Wu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Clinical Trial Registry, Chinese Ethics Committee of Registering Clinical Trials; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A","family":"Lawrie","sequence":"additional","affiliation":[{"name":"Royal United Hospital; Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group; Education Centre Bath UK BA1 3NG"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"issue":"3 (part 1)","key":"10.1002\/14651858.CD005196.pub4-BIB0001|cit1","first-page":"357","article-title":"A prospective randomised comparison of methotrexate, dactinomycin and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in \"poor prognosis\" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group Study","volume":"73","author":"Curry","year":"1989","journal-title":"Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD005196.pub4-BIB0002|cit2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007102.pub3","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","author":"Alazzam","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD005196.pub4-BIB0003|cit3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008891.pub2","article-title":"Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia","author":"Alazzam","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E","article-title":"Risk and prognostic factors in trophoblastic neoplasia","volume":"38","author":"Bagshawe","year":"1976","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0005|cit5","first-page":"192","article-title":"Treatment of trophoblastic tumours","volume":"62","author":"Bagshawe","year":"1977","journal-title":"Recent Results Cancer Research"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(86)90179-0","article-title":"Hydatidiform mole in England and Wales, 1973-1983","volume":"ii","author":"Bagshawe","year":"1986","journal-title":"Lancet"},{"issue":"7-8","key":"10.1002\/14651858.CD005196.pub4-BIB0007|cit7","first-page":"341","article-title":"Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital","volume":"57","author":"Bianconi","year":"2012","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0090-8258(88)80029-5","article-title":"EMA\/CO regimen in high-risk gestational trophoblastic tumour","volume":"31","author":"Bolis","year":"1988","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0009|cit9","first-page":"2639","article-title":"EMA-CO for high-risk gestational trophoblastic tumours: results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"5-6","key":"10.1002\/14651858.CD005196.pub4-BIB0010|cit10","first-page":"231","article-title":"High-risk metastatic gestational trophoblastic neoplasia. Primary management with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy","volume":"57","author":"Cagayan","year":"2012","journal-title":"Journal of Reproductive Medicine"},{"issue":"7-8","key":"10.1002\/14651858.CD005196.pub4-BIB0011|cit11","first-page":"333","article-title":"High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience","volume":"55","author":"Chauhan","year":"2010","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0012|cit12","unstructured":"National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE), v 4.0, June 2010. evs.nci.nih.gov\/ftp1\/CTCAE\/About.html (accessed 12 November 2012)"},{"issue":"6","key":"10.1002\/14651858.CD005196.pub4-BIB0013|cit13","first-page":"219","article-title":"Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy","volume":"56","author":"Cyriac","year":"2011","journal-title":"Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005196.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijgo.2011.04.017","article-title":"Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia","volume":"115","author":"Cyriac","year":"2011","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0015|cit15","volume-title":"The care and treatment of women","author":"Decherney","year":"2003"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0018|cit18","first-page":"1547","article-title":"Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease","volume":"82","author":"Dobson","year":"2000","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0019|cit19","first-page":"2181","article-title":"Trophoblastic growths: morphologic aspects and taxonomy","volume":"26","author":"Driscoll","year":"1981","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2003.08.028","article-title":"Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine chemotherapy","volume":"91","author":"Escobar","year":"2003","journal-title":"Gynecological Oncology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/ijerph9072444","article-title":"Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor","volume":"9","author":"Ezoe","year":"2012","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/annonc\/mdq649","article-title":"Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide and vincristine (FAEV) for patients with relapsed\/chemoresistant gestational trophoblastic neoplasia","volume":"22","author":"Feng","year":"2011","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2008.12.015","article-title":"Current FIGO staging for cancer of the vagina, fallopian tube, ovary and gestational trophoblastic neoplasia","volume":"105","author":"FIGO Committee on Gynecologic Oncology","year":"2009","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0024|cit24","first-page":"6","article-title":"Genetics","volume-title":"Gestational Trophoblastic Disease. www.isstd.org\/isstd\/book.html","author":"Fisher","year":"2009"},{"issue":"7-8","key":"10.1002\/14651858.CD005196.pub4-BIB0025|cit25","first-page":"310","article-title":"Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years","volume":"57","author":"F\u00fcl\u00f6p","year":"2012","journal-title":"Journal of Reproductive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005196.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ijgc-00009577-200403000-00025","article-title":"EMA-EP regimen, as first line multiple agent chemotherapy in high-risk GTT patients (stage II-IV)","volume":"14","author":"Ghaemmaghami","year":"2004","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.hoc.2011.10.007","article-title":"Current management of gestational trophoblastic neoplasia","volume":"26","author":"Goldstein","year":"2012","journal-title":"Hematology Oncology Clinics of North America"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9378(73)90389-X","article-title":"Treatment of metastatic trophoblastic disease: good and poor prognosis","volume":"115","author":"Hammond","year":"1973","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD005196.pub4-BIB0029|cit29","first-page":"306","article-title":"Gestational trophoblastic disease in Sanliurfa, southeast Anatolia, Turkey","volume":"26","author":"Harma","year":"2005","journal-title":"European Journal of Gynaecologic Oncology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/oxfordjournals.aje.a113281","article-title":"Hydatidiform mole in the United States (1970-1977): a statistical and theoretical analysis","volume":"115","author":"Hayashi","year":"1982","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0032|cit32","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0033|cit33","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Good clinical practice consolidated guideline Federal Register 25691 709"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0020-7292(98)80010-6","article-title":"Effects of multi agent chemotherapy and independent risk factors in the treatment of high-risk GTT - 25 years experience of KRI-TRD","volume":"60 Suppl 1","author":"Kim","year":"1998","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1525-1438.2001.011001073.x","article-title":"The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment","volume":"11","author":"Kohorn","year":"2001","journal-title":"International Journal of Gynecologic Cancer"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0143-4004(84)80015-6","article-title":"Intermediate trophoblast: a distinctive form of trophoblast with specific morphological, biochemical, and functional features","volume":"5","author":"Kurman","year":"1984","journal-title":"Placenta"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0037|cit37","first-page":"49","article-title":"Epidemiology","volume-title":"Gestational Trophoblastic Diseases. www.isstd.org\/isstd\/book.html","author":"Lee","year":"2009"},{"issue":"2","key":"10.1002\/14651858.CD005196.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1525-1438.2007.00999.x","article-title":"EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients","volume":"18","author":"Lu","year":"2008","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0039|cit39","first-page":"174","article-title":"Invasive mole","volume":"9","author":"Lurain","year":"1982","journal-title":"Seminars Oncology"},{"issue":"5-6","key":"10.1002\/14651858.CD005196.pub4-BIB0040|cit40","first-page":"199","article-title":"Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7","volume":"55","author":"Lurain","year":"2010","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajog.2010.06.072","article-title":"Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia","volume":"January","author":"Lurain","year":"2011","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD005196.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/gyno.2000.5813","article-title":"Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors","volume":"78","author":"Matsui","year":"2000","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Mazur MT Szulman AE Buchsbaum HJ (editors) Choriocarcinoma and placental site trophoblastic tumour (in gestational trophoblastic disease) New York Springer-Verlag 1987","DOI":"10.1007\/978-1-4612-4698-5"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1471-0528.1986.tb07815.x","article-title":"Developments in chemotherapy for medium and high risk patients with gestational trophoblastic tumours (1979-1984)","volume":"93","author":"Newlands","year":"1986","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"10.1002\/14651858.CD005196.pub4-BIB0045|cit45","first-page":"111","article-title":"Management of resistant gestational trophoblastic tumors","volume":"43","author":"Newlands","year":"1998","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1200\/JCO.2000.18.4.854","article-title":"Etoposide and cisplatin\/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA\/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors","volume":"18","author":"Newlands","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0002-9378(74)90144-6","article-title":"The use of a radioimmunoassay specific for human chorionic gonadotropin in patients with molar pregnancy and gestational trophoblastic disease","volume":"120","author":"Pastorfide","year":"1974","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD005196.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.humpath.2006.04.030","article-title":"Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole","volume":"37","author":"Popiolek","year":"2006","journal-title":"Human Pathology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0049|cit49","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0050|cit50","first-page":"817","article-title":"Etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease","volume":"80","author":"Schink","year":"1992","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0051|cit51","volume-title":"Contemporary therapy in obstetrics and gynecology","author":"Schorge","year":"2003"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0052|cit52","first-page":"277","article-title":"Presentation and management of persistent gestational trophoblastic disease (GTD) and gestational trophoblastic tumours (GTT) in the United Kingdom","volume-title":"Gestational trophoblastic disease. www.isstd.org\/isstd\/book.html","author":"Seckl","year":"2009"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0053|cit53","first-page":"335","article-title":"Investigation and treatment of patients with persistent gestational trophoblastic disease and gestational trophoblastic tumours\/neoplasia in the United Kingdom","volume-title":"Gestational Trophoblastic Disease. www.isstd.org\/isstd\/book.html","author":"Seckl","year":"2009"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","article-title":"Gestational trophoblastic disease","volume":"376","author":"Seckl","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0055|cit55","volume-title":"Diagnosis and treatment of trophoblastic tumours","author":"Song","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD005196.pub4-BIB0056|cit56","first-page":"113","article-title":"Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin\/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease","volume":"83","author":"Soper","year":"1994","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-9378(78)90829-3","article-title":"The syndromes of hydatidiform mole: I. cytogenic and morphologic correlations and II morphologic evolution of the complete and partial mole","volume":"131 and 132","author":"Szulman","year":"1978","journal-title":"American Journal Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0058|cit58","volume-title":"Current Tumourology","author":"Tang","year":"2003"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/ijgc-00009577-200605000-00074","article-title":"Results with EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia","volume":"16","author":"Turan","year":"2006","journal-title":"International Journal of Gynecological Cancer"},{"issue":"3","key":"10.1002\/14651858.CD005196.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ygyno.2006.06.031","article-title":"Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences","volume":"103","author":"Wang","year":"2006","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0061|cit61","unstructured":"WHO Scientific Group Gestational trophoblastic disease Technical Report Series No 692 1990"},{"key":"10.1002\/14651858.CD005196.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0090-8258(86)90119-8","article-title":"Modified Bagshawe's regimen in high-risk gestational trophoblastic disease","volume":"23","author":"Wong","year":"1986","journal-title":"Gynecologic Oncology"},{"issue":"5","key":"10.1002\/14651858.CD005196.pub4-BIB0063|cit63","first-page":"334","article-title":"Gestational trophoblastic tumours with EMA\/CP regime: an analysis of 22 cases","volume":"25","author":"Zhao","year":"2000","journal-title":"Journal of Bengbu Medical School"},{"issue":"2","key":"10.1002\/14651858.CD005196.pub4-BIB0064|cit64","first-page":"88","article-title":"Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China","volume":"54","author":"Zhao","year":"2009","journal-title":"Journal of Reproductive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005196.pub4-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005196.pub3","article-title":"Combination chemotherapy for high-risk gestational trophoblastic tumour","author":"Deng","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005196.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:46:18Z","timestamp":1745937978000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005196.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005196.pub4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985678.793474104","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}